Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
Dr. Salloway, a site principal investigator for trials of the drug, wasn’t paid for that work but has received research and consulting fees from Biogen. He said doctors should use the drug only for patients whose statuses match those in the clinical trials. “There’s no evidence that it could be beneficial for any other stage…
Details